Michele Robertson

Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

Paul R. Kalra, John G.F. Cleland, Mark C. Petrie et al. · The Lancet · 2022 · 344 citations · Full text

Heart Failure, Intravenous Ferric Derisomaltose, Iron Metabolism +3

Safety, Feasibility, and Efficacy of Vagus Nerve Stimulation Paired With Upper-Limb Rehabilitation After Ischemic Stroke

Jesse Dawson, David M. Pierce, Anand Dixit et al. · Stroke · 2015 · 283 citations · Full text

Effects on Outcomes of Heart Rate Reduction by Ivabradine in Patients With Congestive Heart Failure: Is There an Influence of Beta-Blocker Dose?

Karl Swedberg, Michel Komajda, Michael Böhm et al. · Journal of the American College of Cardiology · 2012 · 252 citations

Heart Failure, Cardiovascular Disease, Cardiovascular Pharmacology +8

Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial

Kim Fox, Ian Ford, Michał Tendera et al. · European Heart Journal · 2009 · 218 citations

Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above

Antonio J. Vallejo‐Vaz, Michele Robertson, Alberico L. Catapano et al. · Circulation · 2017 · 180 citations · Full text